Castle Biosciences, Inc. · NASDAQ:CSTL
BlackRock, Inc. reported a 8.20% stake in Castle Biosciences, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed Apr 23, 2025
BlackRock, Inc. reported a 8.20% stake in Castle Biosciences, Inc., 2,338,005 shares, as a passive investor on Mar 31, 2025. Filed Apr 23, 2025 (Schedule 13G/A).
- Stake
- 8.20%
- Shares
- 2,338,005
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 8.20% | 2,338,005 |